timothy sykes logo
LASE Stock Pops As DefenseTech Wins And J&J Order Spark Momentum Thumbnail
G Google News

LASE Stock Pops As DefenseTech Wins And J&J Order Spark Momentum

TIM SYKES•UPDATED JUN. 2, 2026, 9:19 AM ET
Reviewed by Bryce Tuoheyand Fact-checked by Matt Monaco

Laser Photonics Corporation stocks have been trading up by 40.19 percent amid heightened optimism over its industrial laser innovations.

Candlestick Chart

Live Update At 09:18:49 EDT: On Tuesday, June 02, 2026 Laser Photonics Corporation stock [NASDAQ: LASE] is trending up by 40.19%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

LASE is trading like a classic low-priced momentum story trying to turn aggressive product news into real numbers. The recent daily chart shows Laser Photonics stock grinding higher from the mid-$0.80s to the low-$0.90s, with a strong push on 2026/05/28 when LASE spiked from roughly $0.83 to a $0.98 high and closed near $0.93. That move lined up with the Johnson & Johnson order news, and traders clearly reacted.

Intraday, LASE shows a big liquidity surge from sub-$1 premarket to a 1.47 high right after the open, then a fade into the 1.30s. That’s classic low-float, news-driven action: fast expansion, then profit-taking. Active traders see that as confirmation LASE can still attract volume when headlines hit.

Financially, Laser Photonics is early-stage and bleeding cash. Revenue is about $8.34M annually, but margins are deeply negative and free cash flow is around -$5M in the last reported quarter. Current and quick ratios under 1.0 tell traders the balance sheet is tight. For LASE, the story is less about today’s earnings and more about whether these defense and medical wins can eventually flip that cash-burn script.

Why Traders Are Watching LASE Right Now

LASE has lined up exactly the kind of catalysts momentum traders hunt: real-world validation plus sector buzz. The headline win is CMS Laser’s $250K order from Johnson & Johnson for a custom drilling system in medical devices. That number alone will not transform Laser Photonics’ income statement, but it matters. It’s a foot in the door of a high-value, regulated industry with a global name that already knows the company. Traders will watch to see if this turns into repeat or multi-site orders.

On the defense side, LASE has been busy. The DefenseTech Missile Laser Rust Inhibitor system passed pilot deployment at a U.S. Army depot. That is not just a demo; the system reportedly cut maintenance cycle times and improved workflows for missile maintenance. For traders, pilots like this are key tells. A successful test at one depot often precedes wider rollouts if budgets line up.

LASE is also pushing into hot defense tech with its Laser Shield Anti-Drone System, developed with affiliate Fonon Technologies. LSAD has moved from initial testing into system prototyping and extended-range trials, and Laser Photonics plans to showcase it to Defense Directorate Program Executive Offices at SOF Week. That puts LASE in front of exactly the people who sign checks for next-gen counter-drone tools.

Layer on new DefenseTech MRLS portable cleaning and marking systems plus the Blaster Cabinet 4020, and you get a company building a full toolbox for military MRO and logistics. For short-term trading, that expanding narrative can be as important as current revenue, especially in a liquid, sub-$2 LASE chart.

More Breaking News

Conclusion

Laser Photonics is not a clean, profitable machine yet. The latest filings show steep losses, negative equity, and a cash position that forces discipline. That is exactly why the recent LASE news flow matters so much. Traders are not paying attention because everything is perfect; they are watching because the story is changing while the stock still trades under $2.

The Johnson & Johnson order validates LASE technology in a new medical vertical. The DefenseTech missile rust inhibitor pilot anchors Laser Photonics inside the U.S. Army maintenance ecosystem. The LSAD anti-drone roadmap taps into one of the fastest-growing defense themes. Add in the MRLS and Blaster Cabinet launches, and LASE now has multiple shots on goal across defense logistics and field operations.

Governance also tightened with Roman Franklin stepping in as CFO and principal financial officer, bringing deeper SEC and capital markets experience. That kind of hire often shows a small-cap preparing for heavier scrutiny and possible future capital raises.

For active traders studying LASE, the setup is simple but not easy: high risk, heavy dilution history, but increasingly real contracts and pilots. As Tim Sykes loves to remind his community, “The market rewards prepared traders, not hopeful gamblers.” As millionaire penny stock trader and teacher Tim Sykes, says, “It’s not about how much money you make; it’s about how much money you keep.”. With LASE, preparation means tracking every new contract, defense trial, and balance-sheet move before chasing the next spike. This article is for educational and research purposes only and is not investment advice.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply

Click Here for a Millionaire's POV on Trading LASE

Millionaire's
POV on LASE

Don't miss the next
big breakout.

GET POV
Tim Sykes

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”